Recommended Vaccines for Immunocompetent Older Adults: A Work Group Report of the AAAAI Asthma, Allergic & Immunologic Diseases in Older Adults Committee

Document Type

Article

Publication Date

4-1-2026

Publication Title

J Allergy Clin Immunol Pract

Keywords

Humans, Aged, Vaccination, United States, Vaccines, COVID-19, Practice Guidelines as Topic, SARS-CoV-2, Immunocompetence, Advisory Committees, Aged, 80 and over

Abstract

Adults 65 years or older are more susceptible to infectious diseases, representing a significant public health concern worldwide. Although newer vaccines have been developed for older adults, confusion over frequently changing guidelines often contributes to vaccine hesitancy and low vaccination rates. An American Academy of Allergy, Asthma & Immunology work group was convened to provide a clearer summary of these guidelines from the Advisory Committee on Immunization Practices and the Centers for Disease Control and Prevention. This article reviews the epidemiology and pathology of key infectious diseases in older adults, the mechanism of action of the vaccines targeting these diseases, commercially available vaccines, their potential side effects, and current vaccination recommendations for adults 65 years or older. The primary focus of this work is on adults 65 years or older; however, when possible, newer vaccination recommendations that begin at age 50 years have also been included. The diseases covered in this review include coronavirus disease 2019, pneumococcal pneumonia, respiratory syncytial virus, influenza, shingles, and tetanus. A summary table of vaccination guidelines is also included in Table III.

Medical Subject Headings

Humans; Aged; Vaccination; United States; Vaccines; COVID-19; Practice Guidelines as Topic; SARS-CoV-2; Immunocompetence; Advisory Committees; Aged, 80 and over

PubMed ID

41823941

Volume

14

Issue

4

First Page

791

Last Page

801

Find It @ Sladen

Share

COinS